 Connection
James Marsh to Treatment Outcome
This is a "connection" page, showing publications James Marsh has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.215 |
|
|
|
-
Culp WC, Onteddu SS, Brown A, Nalleballe K, Sharma R, Skinner RD, Witt T, Roberson PK, Marsh JD. Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Randomized and Controlled Dose-Escalation Trial. J Vasc Interv Radiol. 2019 Aug; 30(8):1244-1250.e1.
Score: 0.081
-
Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD. Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department. Vasc Health Risk Manag. 2013; 9:187-93.
Score: 0.053
-
Sharma RK, Voelker DJ, Sharma R, Reddy HK, Dod H, Marsh JD. Evolving role of platelet function testing in coronary artery interventions. Vasc Health Risk Manag. 2012; 8:65-75.
Score: 0.048
-
Teeter MG, Marsh JD, Howard JL, Yuan X, Vasarhelyi EM, McCalden RW, Naudie DDR. A randomized controlled trial investigating the value of patient-specific instrumentation for total knee arthroplasty in the Canadian healthcare system. Bone Joint J. 2019 May; 101-B(5):565-572.
Score: 0.020
-
Xiong WW, Karam PY, Marsh JD, Varma N, Verdino RJ, Paydak H. Innovative P-wave detection for discrimination between ventricular and supraventricular tachycardia in single-chamber ICDs: is the P-wave invisible during tachycardia? Europace. 2013 Jun; 15(6):827-34.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|